Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

PLGA-Based Pharmaceutical Delivery Systems

The uptake of PLGA nanoparticles containing ligands for TLR-4 (monophosphoryal lipid A) or TLR-9 (immunostimula-tory CpG oligonucleotides) by DCs resulted in the upregulation [Pg.465]

Antigen-loading of DCs by PLGA Nanoparticles Ex Vivo for Induction of T Cell Responses [Pg.468]

Antigen delivery to DCs ex vivo is of particular significance to cancer immunotherapy. As already discussed, cancer may induce defects in DCs in cancer patients and may create an [Pg.468]

Immune Responses In Vivo Thl/Th2 Balance and Anticancer Effects [Pg.472]

Particulate vaccine delivery systems seek to target DCs making use of their phagocytic properties. Since the upper size limit reported for phagocytosis by macrophages, closely [Pg.474]

See other pages where PLGA-Based Pharmaceutical Delivery Systems is mentioned: [Pg.464]    [Pg.464]    [Pg.562]    [Pg.334]    [Pg.216]    [Pg.463]    [Pg.464]    [Pg.146]    [Pg.334]    [Pg.254]    [Pg.478]    [Pg.357]    [Pg.187]    [Pg.488]   


SEARCH



Based delivery systems

PLGA

PLGAs

Pharmaceutical delivery system

Pharmaceutical systems

© 2024 chempedia.info